Nature's Sunshine Products Inc. (NATR)
NASDAQ: NATRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NATR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $176.41M
- P/E (TTM)
- 12.41
- Forward P/E
- 10.77
- EPS (TTM)
- $0.82
- Dividend yield
- None
- Ex-dividend date
- Mar 26, 2021
- 52-week range
- 9.38 – 28.14
- Day range
- 10.05 – 10.35
- Volume / Avg
- 318.11K / 168.24K
- Beta
- —
- Shares outstanding
- 17.33M
52-week range
NATR stock today
On Nov 20, NATR ended the session at $10.18, adding $0.01 (0.10%), versus the S&P 500's 3.70% decline. Shares are 63.8% below their 52-week high of $28.14, set on Mar 2, 2026 and 8.5% above the 52-week low of $9.38, near the bottom of the past year's range. NATR is down 52.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 51.8%.
Nature's Sunshine Products trades at 12.4x its trailing twelve-month earnings per share of $0.82. Its forward P/E of 10.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Nature's Sunshine Products
Company profileNature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate intestinal and digestive functions; personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Kenneth G. Romanzi
- Headquarters
- Lehi, UT
- Employees
- 806
- Website
- naturessunshine.com
Financial highlights
Full financialsIn fiscal 2025, Nature's Sunshine Products generated $480.1 million in revenue, up 5.7% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $19.5 million (+153.7% year over year), for a net margin of 4.1% versus a median of 3.4% in the prior 5 years. Gross margin was 72.4% (up from 71.5%) and operating margin 5.2%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $480.14M | $454.36M | $445.32M | $421.91M | $444.08M |
| Growth | +5.67% | +2.03% | +5.55% | -4.99% | +15.29% |
| Net income | $19.52M | $7.70M | $15.08M | $-390.00K | $30.21M |
| EPS (diluted) | $1.06 | $0.40 | $0.77 | $-0.02 | $1.42 |
Analyst forecast
ForecastConsensus (2 analysts)
strong_buy
Avg. price target
$16.50+62.08%
- Strong buy 0
- Buy 2
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 4, 2026
- EPS actual vs est.
- $0.11 vs —
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $1.00
- Ex-dividend date
- Mar 26, 2021
NATR news
All NATR newsNature's Sunshine Products peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| VOGXVogenx Inc | 11.87 | -7.30% | $176.33M | vs NATR |
| SIGASIGA Technologies Inc. | 2.40 | -9.43% | $172.45M | vs NATR |
| ADCTADC Therapeutics SA | 1.28 | -1.54% | $180.05M | vs NATR |
| SLGLSol-Gel Technologies Ltd. | 55.17 | +2.02% | $180.63M | vs NATR |
| WHWKWhitehawk Therapeutics Inc. | 3.07 | -1.60% | $181.16M | vs NATR |
| TRDAEntrada Therapeutics Inc. | 4.35 | -6.25% | $170.30M | vs NATR |
| KRROKorro Bio Inc. | 12.18 | -0.08% | $167.18M | vs NATR |
| ABEOAbeona Therapeutics Inc. | 2.42 | -1.22% | $165.31M | vs NATR |
Indexes, lists and sector
Nature's Sunshine Products stock FAQ
What is Nature's Sunshine Products's stock price today?
NATR last traded at $10.18 as of Nov 20, 4:00 PM EST, up 0.10% on the day. Prices are delayed at least 15 minutes.
Does Nature's Sunshine Products pay a dividend?
Yes. Nature's Sunshine Products pays $0.00 per share annually. The most recent dividend of $1.00 had an ex-dividend date of Mar 26, 2021.
What is NATR's P/E ratio?
NATR trades at a trailing P/E ratio of 12.41 and a forward P/E of 10.77.
Who is Nature's Sunshine Products's CEO?
Mr. Kenneth G. Romanzi is the chief executive officer of Nature's Sunshine Products Inc., which has about 806 employees.
What is the NATR 52-week high?
The 52-week high for NATR is $28.14 and the 52-week low is $9.38. The stock is currently 63.8% below its high.